Michael S. Anderson, Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL), sold 32,594 shares at $4.91 ($160K) on 2018-08-10, disclosed to the SEC on 2018-08-14.
Open-market sale of $160k AVDL by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.91 | 16,297 | $80K | 50.0% |
| 2 | $4.91 | 16,297 | $80K | 50.0% |
| Total | $4.91 avg | 32,594 | $160K | 100% |
| Filing → |
| AVDL | BUY | 2017-12-11 | $44K | — | Filing → |
| AVDL | BUY | 2017-09-14 | $39K | — | Filing → |
| AVDL | BUY | 2017-05-22 | $25K | — | Filing → |